Clinical evaluation of an interstitial remote afterloading device for multichannel intracavitary irradiation. 1995

P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
Radiation Oncology Center, Mallinckrodt Institute of Radiology, Washington University School of Medicine, St. Louis, MO 63110.

OBJECTIVE The purpose of this report is to describe the clinical implementation and evaluation of an interstitial remote afterloading device for multichannel intracavitary brachytherapy. METHODS Two 15-channel low dose rate devices were adapted for use with Fletcher-Suit tandem and ovoids and Simon-Heyman capsules. The technical records for 103 intracavitary brachytherapy procedures performed from February 1989 through February 1991 were reviewed. RESULTS Isodose distributions from fixed source trains for Microselectron low dose rate gynecologic applicators closely approximate standard manual afterloading sources and applicators. Device malfunctions occurred in 51% (53 out of 103) of the procedures. Malfunctions by applicator type were 70% (51 out of 73) for tandem, ovoids, and capsules, 12% (2 out of 17) for tandem and ovoids, and none (0 out of 13) for ovoids only. The most common malfunction occurred during source transfer. Total implant time was prolonged 0 to 4% by malfunction and 10% by patient care interruptions, depending on applicator type. CONCLUSIONS The adaptation of the Microselectron device for multichannel gynecologic intracavitary brachytherapy results in similar dose distributions as standard manual after loading sources and a decreased radiation exposure to nursing personnel. The system has a high rate of malfunctions but a low overall prolongation of implant time due to malfunction.

UI MeSH Term Description Entries
D001918 Brachytherapy A collective term for interstitial, intracavity, and surface radiotherapy. It uses small sealed or partly-sealed sources that may be placed on or near the body surface or within a natural body cavity or implanted directly into the tissues. Curietherapy,Implant Radiotherapy,Plaque Therapy, Radioisotope,Radioisotope Brachytherapy,Radiotherapy, Interstitial,Radiotherapy, Intracavity,Radiotherapy, Surface,Brachytherapy, Radioisotope,Interstitial Radiotherapy,Intracavity Radiotherapy,Radioisotope Plaque Therapy,Radiotherapy, Implant,Surface Radiotherapy,Therapy, Radioisotope Plaque
D002583 Uterine Cervical Neoplasms Tumors or cancer of the UTERINE CERVIX. Cancer of Cervix,Cancer of the Cervix,Cancer of the Uterine Cervix,Cervical Cancer,Cervical Neoplasms,Cervix Cancer,Cervix Neoplasms,Neoplasms, Cervical,Neoplasms, Cervix,Uterine Cervical Cancer,Cancer, Cervical,Cancer, Cervix,Cancer, Uterine Cervical,Cervical Cancer, Uterine,Cervical Cancers,Cervical Neoplasm,Cervical Neoplasm, Uterine,Cervix Neoplasm,Neoplasm, Cervix,Neoplasm, Uterine Cervical,Uterine Cervical Cancers,Uterine Cervical Neoplasm
D004867 Equipment Design Methods and patterns of fabricating machines and related hardware. Design, Equipment,Device Design,Medical Device Design,Design, Medical Device,Designs, Medical Device,Device Design, Medical,Device Designs, Medical,Medical Device Designs,Design, Device,Designs, Device,Designs, Equipment,Device Designs,Equipment Designs
D004868 Equipment Failure Failure of equipment to perform to standard. The failure may be due to defects or improper use. Defects, Equipment,Device Failure,Failure, Equipment,Malfunction, Equipment,Medical Device Failure,Misuse, Equipment,Device Failure, Medical,Device Failures, Medical,Failure, Medical Device,Failures, Medical Device,Defect, Equipment,Device Failures,Equipment Defect,Equipment Defects,Equipment Failures,Equipment Malfunction,Equipment Malfunctions,Equipment Misuse,Equipment Misuses,Failure, Device,Failures, Device,Failures, Equipment,Malfunctions, Equipment,Misuses, Equipment
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D016889 Endometrial Neoplasms Tumors or cancer of ENDOMETRIUM, the mucous lining of the UTERUS. These neoplasms can be benign or malignant. Their classification and grading are based on the various cell types and the percent of undifferentiated cells. Cancer of Endometrium,Endometrial Cancer,Endometrial Carcinoma,Cancer of the Endometrium,Carcinoma of Endometrium,Endometrium Cancer,Neoplasms, Endometrial,Cancer, Endometrial,Cancer, Endometrium,Cancers, Endometrial,Cancers, Endometrium,Carcinoma, Endometrial,Carcinomas, Endometrial,Endometrial Cancers,Endometrial Carcinomas,Endometrial Neoplasm,Endometrium Cancers,Endometrium Carcinoma,Endometrium Carcinomas,Neoplasm, Endometrial

Related Publications

P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
January 1978, Journal of the National Medical Association,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
October 1975, Radiology,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
January 1965, Progress in clinical cancer,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
August 1964, Radiology,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
January 1992, European urology,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
April 1983, Rinsho hoshasen. Clinical radiography,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
August 1963, The American journal of roentgenology, radium therapy, and nuclear medicine,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
December 1983, No shinkei geka. Neurological surgery,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
August 1987, Radiology,
P W Grigsby, and E D Slessinger, and S P Teague, and J F Williamson, and C A Perez
November 1990, The Journal of the Oklahoma State Medical Association,
Copied contents to your clipboard!